About Defenxa
Defenxa is a Healthcare company founded in 2020. It provides rapid COVID-19 serological tests and health management apps for consumers. It operates on a B2C and B2B model. Defenxa offers products and services including COVID-19 Test Kit and DEFENXA App. Its focus areas include Diagnostic Tech, Infectious Disease Testing, COVID-19 Serological Tests and Digital Health.
Company details
DEFENXA specializes in creating portable, rapid serological tests for COVID-19 antibodies, using immunofluorescence technology for accurate results in under 10 minutes. The company offers an app for users to book and manage at-home tests, as well as tools for professionals. Based in Vaprio dAdda, Italy, it serves individuals and healthcare providers with certified medical devices registered with the Italian Ministry of Health. Products are designed for ease of use and quick deployment in various settings.
- SectorsHealthcare
- Website defenxa.com
Products & Services of Defenxa
Defenxa offers a comprehensive portfolio of products and services, including COVID-19 Test Kit and DEFENXA App.
Rapid serological test for detecting COVID-19 antibodies quickly.
Mobile app for booking and managing COVID-19 tests easily.
Top companies in Infectious Diseases
10 companies that operate in the same segment as Defenxa (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | 172 | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | 329 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Defenxa
Defenxa was founded in 2020.
DEFENXA specializes in creating portable, rapid serological tests for COVID-19 antibodies, using immunofluorescence technology for accurate results in under 10 minutes. The company offers an app for users to book and manage at-home tests, as well as tools for professionals. Based in Vaprio dAdda, Italy, it serves individuals and healthcare providers with certified medical devices registered with the Italian Ministry of Health. Products are designed for ease of use and quick deployment in various settings.
Defenxa offers COVID-19 Test Kit and DEFENXA App.